Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07698509

Virtual Lifestyle Medicine Group Visits for High Blood Pressure

The purpose of this study is to learn whether virtual Lifestyle medicine shared medical appointments (LMSMAs) can help people better manage their blood pressure and improve their overall health.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current diagnosis of hypertension (ICD codes I10.0-I14.0 billed within the last 5 years Essential HTN, Essential HTN, Primary HTN)
  • Currently receives care at a UTPhysicians; Last seen by a PCP at Victory location within the last 1 year.
  • Able to participate in a virtual format
  • Willingness to participate and engage in home blood pressure monitoring

Exclusion criteria

  • Unstable cardiovascular disease (recent Myocardial Infarction (MI), unstable angina, decompensated HF)
  • Advanced Chronic kidney disease (CKD) (eGFR < 30) without nephrology co-management
  • Active cancer treatment
  • Severe cognitive impairment (unable to engage)
  • Uncontrolled psychiatric illness (e.g., active psychosis)
  • Resistant hypertension (requiring> 3 medications at maximum doses)
  • Unable to participate in English class format
  • Unstable internet or lack of smartphone

Treatment and study plan

Lifestyle Medicine Virtual group

Behavioral

Participants will be given a home BP monitor upon enrollment and the group will engage in twice monthly virtual shared medical appointments (vSMAs) for 4 visits. Prior to each visit, participants will be asked to complete home BP monitoring (twice in the morning and twice in the evening for 3 days before visit), with readings reviewed during visits and medications adjusted as clinically indicated. Participants will complete four sessions over an 8-week period, with one session type offered in each 2 week block.

Usual Care Group

Behavioral

Participants will be given a home BP monitor upon enrollment and will be instructed by phone and with an electronic health record (EHR) portal message on proper technique for home BP readings. Participants will continue to have follow-up visits with their PCP as clinically indicated.

Primary outcomes

  1. Change in diastolic blood pressure readings

    Time frame: 2-4 weeks after randomization,6 months after randomization

  2. Change in systolic blood pressure readings

    Time frame: 2-4 weeks after randomization,6 months after randomization

Secondary outcomes

  1. Percentage of eligible participants who agree to participate

    Time frame: end of study (6 months after randomization)

  2. Number of primary care physicians (PCPs) whose patients are included in the program

    Time frame: end of study (6 months after randomization)

  3. Median number of sessions attended by each participant

    Time frame: end of study (6 months after randomization)

  4. Adherence as assessed by the number of of blood pressure (BP) readings submitted between each session

    Time frame: end of study (6 months after randomization)

  5. Adherence to home BP monitoring as assessed by the number of of home BP sessions submitted between each session

    Time frame: end of study (6 months after randomization)

Study contacts

Contact information is provided by the study sponsor or research team.

Natalia Williams

CONTACT

[email protected]

(713) 486-3844

Puja B Gandhi, MD, MPH, DipABLM

CONTACT

[email protected]

(713) 500-6714

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Registry information

Official study title

A Scalable, Lifestyle Medicine Intervention for Hypertension Using Virtual Group Shared Medical Appointments

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 13, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.